Kouper, a health technology platform designed to transform transitions of care, formally emerged from stealth with $10 million in funding from General Catalyst, 25Madison, and CVS Health Ventures. The company’s mission is to support the millions of patients transitioning across health care settings annually in the United States.
The period following hospital discharge is widely recognized as the most critical-and vulnerable-in a patient’s care journey. Without thoughtful management, patient outcomes and health care spending can spiral out of control, contributing to over $53B in annual avoidable readmission costs. Kouper addresses this challenge by leveraging AI-powered infrastructure to improve patient engagement, automate scheduling, and capture data as patients move from the emergency room, inpatient, and urgent care settings.
“The journey through the American health care system is fraught with challenges and can be particularly difficult when transitioning from the hospital to the home setting,” said Salman Ali, Co-Founder and CEO of Kouper. “A combination of our team’s lived experience and iteration with our incubation partner 25m Health laid the foundation for Kouper and our absolute focus on creating a personalized transition of care experience for every patient leaving the hospital. Our team and customer base are growing rapidly and the validation we’ve received from our health system customers has been incredibly encouraging.”
Also Read: PwC and FloQast and PwC Belgium Announce Strategic Partnership to Transform Financial Close
Kouper is redefining how health care organizations manage patient care transitions by directly integrating with health systems to harness real-time, contextual data across the care continuum. Its AI-powered data platform unifies fragmented, siloed information to deliver a rich, longitudinal view of the patient journey—especially following hospital-based events.
“Kouper is solving one of the most critical challenges in health care by addressing the failures in care transitions that hurt patients and burden systems. Salman, Ablimit, and the team are building core infrastructure that brings accountability, continuity, and better outcomes. We are proud to support their patient centered, data driven approach as they expand to more health systems across the country. This is Health Assurance in action,” said Chris Bischoff, Managing Director and Global Head of Health Assurance at General Catalyst.
“Salman and Ablimit are passionate about simplifying care transitions, and their deep empathy shines through in both the quality of their product and the tens of thousands of patients they’ve helped. With new mandatory episode-based payment models like TEAM emerging, it’s more important than ever for health systems to adopt Kouper’s comprehensive, AI agent-powered transitions of care platform at scale. We’re proud to continue supporting the team as they bring their vision to life,” said Merrill Anovick, General Partner at 25Madison.
SOURCE: Businesswire